Friday, October 1, 10 AM EST
Join us as we discuss what defines psychedelics in the new world of psychedelic-assisted therapies. Does the umbrella term ‘psychedelic’ apply to ketamine and other compounds in the new family of post-60s mind-altering medicines? Most importantly, in any kind of therapy, it’s vital to have a common language for patients and practitioners alike. When it comes to psychedelics, how do we develop this language, and what are the implications for future practitioners?